FDAnews Drug Daily Bulletin

ENDO TO SELL 26 MILLION SHARES IN SECONDARY OFFERING

Sept. 28, 2005
A A

Endo Pharmaceuticals Holdings Inc. (ENDP.O: Quote, Profile, Research) on Monday said its largest shareholder, an affiliate of private equity firm Kelso & Co., was selling the majority of shares in a 26-million-share secondary offering. After the sale, the Kelso affiliate will own about 20.5 percent of Endo's outstanding shares. Endo said it will not receive any proceeds from the offering.

Reuters (http://today.reuters.com/investing/financeArticle.aspx?type=newIssuesNews&storyID=2005-09-26T205125Z_01_WEN9822_RTRIDST_0_HEALTH-ENDO-URGENT.XML)